West Pharmaceutical Services, Inc. (NYSE:WST) SVP Sells $595,404.00 in Stock

West Pharmaceutical Services, Inc. (NYSE:WST) SVP Silji Abraham sold 1,800 shares of the business’s stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $330.78, for a total value of $595,404.00. Following the completion of the sale, the senior vice president now owns 2,860 shares in the company, valued at $946,030.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

West Pharmaceutical Services Stock Performance

NYSE:WST opened at $333.25 on Friday. The company has a market cap of $24.27 billion, a price-to-earnings ratio of 43.96, a PEG ratio of 5.88 and a beta of 1.01. West Pharmaceutical Services, Inc. has a 1 year low of $310.42 and a 1 year high of $415.73. The stock’s 50 day simple moving average is $353.78 and its two-hundred day simple moving average is $361.82. The company has a debt-to-equity ratio of 0.03, a current ratio of 2.61 and a quick ratio of 1.95.

West Pharmaceutical Services (NYSE:WST) last released its quarterly earnings results on Thursday, April 25th. The medical instruments supplier reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.29 by $0.27. West Pharmaceutical Services had a net margin of 19.42% and a return on equity of 20.57%. The company had revenue of $695.40 million for the quarter, compared to the consensus estimate of $670.62 million. During the same quarter in the prior year, the firm earned $1.98 earnings per share. West Pharmaceutical Services’s revenue was down 3.0% on a year-over-year basis. As a group, equities analysts anticipate that West Pharmaceutical Services, Inc. will post 7.76 earnings per share for the current fiscal year.

West Pharmaceutical Services Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 7th. Shareholders of record on Wednesday, July 31st will be paid a dividend of $0.20 per share. The ex-dividend date is Wednesday, July 31st. This represents a $0.80 annualized dividend and a yield of 0.24%. West Pharmaceutical Services’s payout ratio is currently 10.55%.

Institutional Investors Weigh In On West Pharmaceutical Services

Several institutional investors have recently modified their holdings of the stock. Fidelis Capital Partners LLC purchased a new stake in West Pharmaceutical Services during the 1st quarter valued at $27,000. Quarry LP increased its position in West Pharmaceutical Services by 155.3% during the fourth quarter. Quarry LP now owns 97 shares of the medical instruments supplier’s stock valued at $34,000 after acquiring an additional 59 shares during the last quarter. Planned Solutions Inc. purchased a new stake in shares of West Pharmaceutical Services in the fourth quarter valued at $39,000. Hazlett Burt & Watson Inc. bought a new stake in shares of West Pharmaceutical Services in the 1st quarter worth about $40,000. Finally, Northwest Investment Counselors LLC purchased a new position in shares of West Pharmaceutical Services during the 1st quarter worth about $40,000. 93.90% of the stock is owned by institutional investors.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.